Ładuje się......
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
In the past decade, advances in the use of monoclonal antibodies (mAbs) and adoptive cellular therapy to treat cancer by modulating the immune response have led to unprecedented responses in patients with advanced-stage tumours that would otherwise have been fatal. To date, three immune-checkpoint-b...
Zapisane w:
| Wydane w: | Nat Rev Clin Oncol |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2016
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5551685/ https://ncbi.nlm.nih.gov/pubmed/26977780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2016.25 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|